MXCT Stock Analysis: Buy, Sell, or Hold?
MXCT - MaxCyte, Inc. Common Stock
$0.68
-0.01 (-1.18%)
▼
5d:
-10.75%
30d:
-16.73%
90d:
-58.04%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When MXCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MXCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MXCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MXCT is currently trading at $0.68, which is considered oversold relative to its 30-day fair value range of $0.72 to $0.81.
Technical Outlook: Technically, MXCT is in a strong downtrend. The price is currently testing key support at $0.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MXCT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.05 (+492.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MXCT is in a strong downtrend. The price is currently testing key support at $0.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MXCT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.05 (+492.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.72 -
$0.81
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 492.8% below Wall St target ($4.05)
- CAUTION: 5-day price weakness (-10.7%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.72 -
$0.81
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.66
Resistance Level
$0.84
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.61
Wall Street Target
$4.05
(+492.8%)
Revenue Growth (YoY)
-16.0%
Profit Margin
-135.1%
Share & Embed Analysis
Last updated: March 30, 2026 2:57 PM ET
Data refreshes hourly during market hours. Next update: 3:57 PM
Data refreshes hourly during market hours. Next update: 3:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MXCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 51 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 48 HOLD |
